Using virtual reality to manage pain in children with cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of virtual reality helmets in reducing pain during invasive medical procedures for pediatric oncology patients. It involves a randomized controlled design with two groups: one receiving standard care plus virtual reality and the other receiving standard care alone. Pain intensity will be measured using a visual analog scale during procedures such as central venous catheter puncture, lumbar puncture, and bone marrow aspiration. The study aims to determine if virtual reality can significantly alleviate pain in children undergoing these treatments.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* patient who tolerates the virtual reality headset
* patient followed in pediatric oncology
* patient with a diagnosis of benign tumor or cancer
* patient who needs to have painful medical procedure during their treatment
* patient whose parents have signed the informed consent
* patient affiliated with social security or equivalent

Exclusion Criteria:

* patient with visual or hearing impairement
* patient with epilepsy or other neurological disease
* patient with psychiatric disease

Where it's running

• CHU de La Réunion
  Saint-Denis, Reunion Recruiting

Study contacts

• Principal investigator: Yves REGUERRE — CHU de La Réunion
• Study coordinator: Yves REGUERRE
• Email: yves.reguerre@chu-reunion.fr
• Phone: +262262905676

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Glioblastoma in Réunion: an epidemiological and socio-anthropological look at patients and care

  A large group of adults with diffuse gliomas in Réunion is being studied to understand how biology, culture, and health care pathways affect diagnosis and treatment.

  Recruiting Centre Hospitalier Universitaire de la Réunion · Saint-Pierre · NCT07865195

• Curcumin, Ginger and Piperine for Joint Pain in Ultra-Endurance Runners

  This study tests whether a 30-day supplement blend can reduce knee pain and inflammation during a 175-km ultra-marathon in runners.

  Recruiting Centre Hospitalier Universitaire de la Réunion · Saint-Pierre, CHU de La Réunion · NCT07699575

• Simple tool to detect early decompensated heart failure in people 55+ on Réunion Island

  A quick questionnaire-based screening tool is tested in adults 55 and older admitted to cardiology units in Réunion to see if it can identify decompensated heart failure early.

  Recruiting Centre Hospitalier Universitaire de la Réunion · Saint-Denis, Reunion and 2 other locations · NCT07673562

• Herbal Medicine Use in CKD Patients on Réunion Island

  This study tests how common herbal medicine use is among adults with chronic kidney disease (stages 3–5) on Réunion Island and whether it relates to kidney disease progression over a year.

  Recruiting at 4 sites Centre Hospitalier Universitaire de la Réunion · Saint-Benoît and 3 other locations · NCT07444515

• Self-swab versus clinician-collected HPV screening for vulnerable women in Reunion

  This study tests whether self-collected swabs work as well and feel as acceptable as clinician-collected swabs for HPV screening in vulnerable women aged 30–65.

  Recruiting at 2 sites Centre Hospitalier Universitaire de la Réunion · Saint-Paul and 1 other locations · NCT07438080

• Plasma transfusion to protect newborns exposed to chikungunya from brain inflammation

  This trial will test whether giving plasma from a recent chikungunya-infected donor to newborns whose mothers had chikungunya around delivery helps prevent encephalitis or encephalopathy in the first five days of life.

  Recruiting at 2 sites Centre Hospitalier Universitaire de la Réunion · Saint-Pierre and 2 other locations · NCT07190560

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.